Axonics, Inc.
Clinical trials sponsored by Axonics, Inc., explained in plain language.
Medical device company focused on sacral neuromodulation for bladder and bowel disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device trial offers hope for bladder and bowel leakage Results expected Sep 2026 (estimated)
- No more charging: new implant aims to ease bladder and bowel leaks Results expected Dec 2026 (estimated)
- Rechargeable implant offers hope for bladder control – but does it last? Results expected Jan 2027 (estimated)
-
Rechargeable implant offers hope for bladder control – but does it last?
Disease control Recruiting nowThis study is following 55 adults who have an implanted device that stimulates nerves to control overactive bladder. Researchers want to see if the device safely improves quality of life over the long term. Participants must have already tried other treatments without success.
Sponsor: Axonics, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New implant aims to control bowel leakage
Disease control Recruiting nowThis study is testing a rechargeable device that sends mild electrical pulses to nerves in the lower back to help people with fecal incontinence (unexpected bowel leakage). About 55 adults will get the implant and be followed for 2 years. The goal is to see if the device improves…
Sponsor: Axonics, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device aims to quiet overactive bladder in men
Symptom relief Recruiting nowThis study tests a device called the Axonics SNM System, which uses mild electrical pulses to calm the nerves that control the bladder. It is for men with overactive bladder, including those with urgency incontinence or frequent urination. The trial will enroll 150 men and track …
Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New device trial offers hope for bladder and bowel leakage
Symptom relief Recruiting nowThis study is testing a new external device (Axonics ETS-02) to see if it is safe and works for people with overactive bladder or fecal incontinence. About 75 adults will wear the device for a short trial period. The goal is to check if the device stays attached and works properl…
Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC